Pro-permeability Factors in Diabetic Macular Edema; the Diabetic Macular Edema Treated with Ozurdex Trial

PURPOSE: The Diabetic Macular Edema Treated with Ozurdex (DMEO) Trial measured aqueous pro-permeability factors (PPFs) in diabetic macular edema (DME) patients before and after injection of dexamethasone implant or vascular endothelial growth factor (VEGF)-neutralizing protein and correlated changes...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Am J Ophthalmol
Autori principali: Campochiaro, Peter A., Hafiz, Gulnar, Mir, Tahreem A., Scott, Adrienne W., Zimmer-Galler, Ingrid, Shah, Syed M., Wenick, Adam S., Brady, Christopher J., Han, Ian, He, Lingmin, Channa, Roomasa, Poon, David, Meyerle, Catherine, Aronow, Mary Beth, Sodhi, Akrit, Handa, James T., Kherani, Saleema, Han, Yong, Sophie, Raafay, Wang, Guohua, Qian, Jiang
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2016
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5482180/
https://ncbi.nlm.nih.gov/pubmed/27130369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajo.2016.04.017
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi